JYSELECA® (filgotinib), recommended by the Health Service Executive (HSE) for people with Ulcerative Colitis (UC) in Ireland (1) - PharmiWeb.com
5/3/2022 12:00:00 AM3 years 10 months ago
UC is the most common form of inflammatory bowel disease, affecting approximately 11,000 people in Ireland Patients are typically diagnosed in their 20s and 30s and will live with the burden of UC for the rest of their livesLondon, UK, 2nd May 2022 – Galapago…
- UC is the most common form of inflammatory bowel disease, affecting approximately 11,000 people in Ireland
- Patients are typically diagnosed in their 20s and 30s and will live with th… [+2981 chars] full article...